ArticleMediterranean journal of hematology and infectious diseases2026
CD20 Loss as a Mechanism of Resistance to Mosunetuzumab in Relapsed Follicular Lymphoma.
Martina Canichella et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.